Myhep 400mg Tablet (Sofosbuvir) – Direct-Acting Antiviral for Hepatitis C

Myhep 400 (Sofosbuvir) (generic equivalent to Sovaldi) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Myhep 400 deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Sofosbuvir (400mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Mylan Pharmaceuticals Pvt Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.